Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2026 Earnings Call Transcript

Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2026 Earnings Call Transcript May 5, 2026

Cytokinetics, Incorporated reports earnings inline with expectations. Reported EPS is $-1.67 EPS, expectations were $-1.67.

Operator: Thank you for standing by, and welcome to the Cytokinetics, Incorporated Q1 2026 earnings conference call. This call is being recorded, and all participants are in a listen-only mode. There will be no question and answer session after the company’s prepared remarks. I would...